• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis . Influence of Pre-Season Antibodies against Influenza Virus on Risk of Influenza Infection among Health Care Personnel

tetano

Editor, Senior Moderator
J Infect Dis


. 2021 Sep 17;jiab468.
doi: 10.1093/infdis/jiab468. Online ahead of print.
Influence of Pre-Season Antibodies against Influenza Virus on Risk of Influenza Infection among Health Care Personnel


Geoffrey J Gorse[SUP] 1 2 [/SUP], Susan M Rattigan[SUP] 3 [/SUP], Alexander Kirpich[SUP] 4 [/SUP], Michael S Simberkoff[SUP] 5 6 [/SUP], Mary T Bessesen[SUP] 7 8 [/SUP], Cynthia Gibert[SUP] 9 [/SUP], Ann-Christine Nyquist[SUP] 8 10 [/SUP], Connie Savor Price[SUP] 8 11 [/SUP], Charlotte A Gaydos[SUP] 12 [/SUP], Lewis J Radonovich[SUP] 13 [/SUP], Trish M Perl[SUP] 14 15 [/SUP], Maria C Rodriguez-Barradas[SUP] 16 17 [/SUP], Derek A T Cummings[SUP] 3 14 [/SUP]



Affiliations

Abstract

Background: The association of hemagglutination inhibition (HAI) antibodies with protection from influenza among healthcare personnel (HCP) with occupational exposure to influenza viruses has not been well-described.
Methods: The Respiratory Protection Effectiveness Clinical Trial was a cluster-randomized, multi-site study that compared medical masks to N95 respirators in preventing viral respiratory infections among HCP in outpatient healthcare settings for 5,180 participant-seasons. Serum HAI antibody titers before each influenza season and influenza virus infection confirmed by polymerase chain reaction were studied over four study years.
Results: In univariate models, the risk of influenza A(H3N2) and B virus infections was associated with HAI titers to each virus, study year, and site. HAI titers were strongly associated with vaccination. Within multivariate models, each log base 2 increase in titer was associated with 15%, 26% and 33-35% reductions in the hazard of influenza A(H3N2), A(H1N1) and B infections, respectively. Best models included pre-season antibody titers and study year, but not other variables.
Conclusions: HAI titers were associated with protection from influenza among HCP with routine exposure to patients with respiratory illness and influenza season contributed to risk. HCP can be reassured about receiving influenza vaccination to stimulate immunity.

Keywords: correlates of protection; health care personnel; hemagglutination inhibition antibodies; influenza virus.
 
Back
Top Bottom